This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Minutes of the PRAC meeting 25-28 November 2024
ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Age...
Pliant Therapeutics has hit the breaks on a mid-stage trial of its lead liver di...
Advice to medical device manufacturers - 2025 Timetable
Request for advice on the clinical development strategy and / or clinical invest...
Guide to manufacturers on the procedure for requesting advice from expert panels...
EMA, in close collaboration with the European Commission, has established a stan...
Human medicines European public assessment report (EPAR): Bridion, sugammadex, D...
Antibody-drug conjugates (ADCs) are revolutionizing oncology, but success requir...
The life sciences industry must step up to reduce the gap between health care sp...
The public misunderstands antibiotic-resistant infections — and so does the FDA.
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedi...
Amid a shakeup in U.S. science, researchers are expressing alarm over the integr...
Berlin, Germany, 6 February 2025 – Ariceum Therapeutics (Ariceum), a private bio...
Documents analyzed by STAT show that big losers under the NIH's cuts to biomedic...
The Howard Hughes Medical Institute abruptly ended a $60 million program to impr...
NORTH CHICAGO, Ill., Feb. 7, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today anno...
NORTH CHICAGO, Ill., Feb. 7, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today anno...
The FDA is alerting patients of a safety concern regarding diabetes devices that...
IRVINE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (...
HOUSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasda...
Human medicines European public assessment report (EPAR): Izelvay, avacincaptad ...